Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.0290-0.0010 (-3.33%)
At close: 04:27PM SGT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,360
2,314
8,907
1,438
1,268
Cost of revenue
1,569
1,831
5,468
471.952
387.779
Gross profit
791.09
483.09
3,439
966.128
880.127
Operating expenses
Research development
871.91
1,091
877.389
1,233
1,072
Selling general and administrative
-
-
-
2,066
-
Total operating expenses
3,936
3,796
4,017
5,465
2,744
Operating income or loss
-3,145
-3,313
-577.881
-4,499
-1,864
Interest expense
189.349
208.349
127.248
6.349
575.668
Income before tax
-5,325
-6,041
-4,684
-4,810
-6,252
Income tax expense
-55.587
-56.587
-33.009
0
0
Income from continuing operations
-5,269
-5,984
-4,651
-4,810
-6,252
Net income
-5,269
-5,984
-4,651
-4,810
-6,252
Net income available to common shareholders
-5,269
-5,984
-4,651
-4,810
-6,252
Basic EPS
-
-0.02
-0.02
-0.02
-0.05
Diluted EPS
-
-0.02
-0.02
-0.02
-0.05
Basic average shares
-
264,992
257,466
242,500
126,171
Diluted average shares
-
265,207
258,096
242,500
126,171
EBITDA
-
-4,581
-3,560
-4,164
-5,285